Heart Rate Variability for Risk Assessment of Myocardial Ischemia in Patients Without Known Coronary Artery Disease: The HRV-DETECT (Heart Rate Variability for the Detection of Myocardial Ischemia) Study.

Ilan Goldenberg,Ronen Goldkorn,Nir Shlomo,Michal Einhorn,Jacob Levitan,Raphael Kuperstein,Robert Klempfner,Bruce Johnson

DOI: https://doi.org/10.1161/JAHA.119.014540

IF: 6.106

2019-12-18

Journal of the American Heart Association

Abstract:Background Detecting significant coronary artery disease (CAD) in the general population is complex and relies on combined assessment of traditional CAD risk factors and noninvasive testing. We hypothesized that a CAD‐specific heart rate variability (HRV) algorithm can be used to improve detection of subclinical or early ischemia in patients without known CAD. Methods and Results Between 2014 and 2018 we prospectively enrolled 1043 patients with low to intermediate pretest probability for CAD who were screened for myocardial ischemia in tertiary medical centers in the United States and Israel. Patients underwent 1‐hour Holter testing, with immediate HRV analysis using the HeartTrends DyDx algorithm, followed by exercise stress echocardiography (n=612) or exercise myocardial perfusion imaging (n=431). The threshold for low HRV was identified using receiver operating characteristic analysis based on sensitivity and specificity. The primary end point was the presence of myocardial ischemia detected by exercise stress echocardiography or exercise myocardial perfusion imaging. The mean age of patients was 61 years and 38% were women. Myocardial ischemia was detected in 66 (6.3%) patients. After adjustment for CAD risk factors and exercise stress testing results, low HRV was independently associated with a significant 2‐fold increased likelihood for myocardial ischemia (odds ratio, 2.00; 95% CI, 1.41–2.89 [ P =0.01]). Adding HRV to traditional CAD risk factors significantly improved the pretest probability for myocardial ischemia. Conclusions Our data from a large prospective international clinical study show that short‐term HRV testing can be used as a novel digital‐health modality for enhanced risk assessment in low‐ to intermediate‐risk individuals without known CAD. Clinical Trial Registration URL: http://www.ClinicalTrials.gov . Unique identifiers: NCT01657006, NCT02201017). Clinical Perspective What Is New? This is the first study to evaluate short‐term heart rate variability (HRV) testing for the detection of myocardial ischemia in individuals with low to intermediate pretest probability for coronary artery disease (CAD) in the setting of a large prospective multicenter clinical study. Low HRV, assessed using the HeartTrends DyDx algorithm, was shown to be independently associated with a 2‐fold increased risk for the presence of myocardial ischemia is individuals without known CAD. HRV testing was shown to provide incremental diagnostic yield to traditional CAD risk factors and to exercise stress testing for the detection of myocardial ischemia. What Are the Clinical Implications? Short‐term HRV testing with the HeartTrends DyDx algorithm can be used as a novel digital‐health modality for enhanced detection of myocardial ischemia in patients without known CAD. The test can be used in conjunction with traditional cardiovascular risk factors to identify individuals without known CAD who have an increased likelihood for the presence of myocardial ischemia. In the era of wearable digital monitoring devices and increased interest in personalized approaches to risk assessment, HRV may provide useful information to direct lifestyle change and to monitor general health status. Coronary artery disease (CAD) is a major public health problem accounting for the majority of deaths in the United States. 1 Patients are frequently asymptomatic or exhibit nontypical symptoms until ischemic heart disease manifests itself as sudden cardiac death or myocardial infarction. Detecting significant CAD in patients without known disease is complex and relies on combined assessment of traditional cardiovascular risk factors, clinical symptoms, and noninvasive testing. Exercise stress testing (EST) is the most commonly used modality for CAD assessment, but, because of its limited ability to correctly diagnose myocardial ischemia, it is not recommended for screening in the general population 2 , 3 , 4 , 5 Accordingly, additional noni -Abstract Truncated-

cardiac & cardiovascular systems